CH625503A5 - Process for preparing rapidly assimilable and readily soluble calcium and magnesium double salts of organic acids - Google Patents

Process for preparing rapidly assimilable and readily soluble calcium and magnesium double salts of organic acids Download PDF

Info

Publication number
CH625503A5
CH625503A5 CH987476A CH987476A CH625503A5 CH 625503 A5 CH625503 A5 CH 625503A5 CH 987476 A CH987476 A CH 987476A CH 987476 A CH987476 A CH 987476A CH 625503 A5 CH625503 A5 CH 625503A5
Authority
CH
Switzerland
Prior art keywords
magnesium
calcium
salts
water
solution
Prior art date
Application number
CH987476A
Other languages
German (de)
English (en)
Inventor
Vasile Georgescu
Constantin Florescu
Maria Dascalita
Original Assignee
Bucuresti Medicamente
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bucuresti Medicamente filed Critical Bucuresti Medicamente
Publication of CH625503A5 publication Critical patent/CH625503A5/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/145Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH987476A 1975-08-05 1976-08-03 Process for preparing rapidly assimilable and readily soluble calcium and magnesium double salts of organic acids CH625503A5 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RO7583091A RO68298A2 (ro) 1975-08-05 1975-08-05 Compozitie pe baza de saruri organice de calciu si magneziu usor asimilabile si cu o solubilitate crescuta,si procedeu de preparare a acesteia

Publications (1)

Publication Number Publication Date
CH625503A5 true CH625503A5 (en) 1981-09-30

Family

ID=20095205

Family Applications (1)

Application Number Title Priority Date Filing Date
CH987476A CH625503A5 (en) 1975-08-05 1976-08-03 Process for preparing rapidly assimilable and readily soluble calcium and magnesium double salts of organic acids

Country Status (7)

Country Link
JP (1) JPS54122216A (zh)
CH (1) CH625503A5 (zh)
DE (1) DE2635293A1 (zh)
FR (1) FR2320089A1 (zh)
GB (1) GB1564135A (zh)
IN (1) IN144366B (zh)
RO (1) RO68298A2 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU84891A1 (fr) * 1983-06-30 1985-03-29 Continental Pharma Derives de l'acide 2-aminoacetique,leur preparation et utilisation ainsi que compositions pharmaceutiques contenant ces derives
JP2891744B2 (ja) * 1989-04-19 1999-05-17 武田薬品工業株式会社 パントテン酸カルシウム組成物およびその製造方法
GB8926486D0 (en) * 1989-11-23 1990-01-10 Ciba Geigy Pesticide composition
CN101209962B (zh) * 2006-12-28 2011-08-24 浙江山下湖珍珠集团股份有限公司 一种葡萄糖酸钙镁的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2454164A1 (de) * 1974-11-15 1976-05-26 Tad Pharm Werk Injektions- bzw. infusionsloesung zur bekaempfung von tetanien bei wiederkaeuern und verfahren zur herstellung derselben

Also Published As

Publication number Publication date
IN144366B (zh) 1978-04-29
GB1564135A (en) 1980-04-02
JPS5761728B2 (zh) 1982-12-25
FR2320089B1 (zh) 1978-11-17
RO68298A2 (ro) 1980-04-15
JPS54122216A (en) 1979-09-21
DE2635293A1 (de) 1977-05-12
FR2320089A1 (fr) 1977-03-04

Similar Documents

Publication Publication Date Title
DE965036C (de) Verfahren zur Herstellung von p-(Bis-2-chloraethyl-amino)-ª‰-phenyl-alanin
DE2423278A1 (de) Verfahren zur herstellung von carbonsaeureestern
DE19653225A1 (de) Kreatin-pyruvate und Verfahren zu deren Herstellung
CH632773A5 (de) Verfahren zur herstellung von reinem steringlykosid aus rohem steringlykosid.
CH621065A5 (zh)
CH644263A5 (de) Fuer kosmetische zwecke verwendbare praeparate und verfahren zur herstellung der wirkstoffe dieser praeparate.
DE2253750C3 (de) Apovincaminsaure-alkylester, Verfahren zu ihrer Herstellung und pharmazeutische
DE1793841B1 (de) trans-4-Aminomethylcyclohexan-1-carbonsaeure und Verfahren zur Herstellung
CH625503A5 (en) Process for preparing rapidly assimilable and readily soluble calcium and magnesium double salts of organic acids
DE2725246C2 (zh)
DE2632118C3 (de) Apovincaminolester und Verfahren zu deren Herstellung und Arzneimittel
DE2004280C3 (de) Verfahren zur Kristallisation von Vitamin D tief 3
DE951865C (de) Verfahren zur Herstellung von AEthylenglykolestern der Terephthalsaeure
DE1812979A1 (de) Antifibrinolytische Verbindungen und Verfahren zu deren Herstellung
DE1963318A1 (de) Silybinhalbester der Bernsteinsaeure und der Phthalsaeure,ihre Salze mit pharmakologisch vertraglichen Basen,Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneipraeparaten
DE2951132C2 (zh)
DE902300C (de) Verfahren zur Herstellung eines therapeutisch wirksamen 17-Oxycorticosteronesters
DE213155C (zh)
DE2305735C2 (de) L-Lysin-Carbamat, Verfahren zu dessen Herstellung und dessen Verwendung in Brausemischungen und Brausemedikamenten
DE957030C (de) Verfahren zur Herstellung der Phenylpropionsaeureester von Steroidhormonen
DE3110190A1 (de) Cephapirinsalze mit aminosaeuren und verfahren zu deren herstellung
DE948158C (de) Verfahren zur Herstellung von Zink-Komplexsalzen von Tripeptiden
DE818047C (de) Verfahren zur Herstellung von konzentrierten neutralen Loesungen des Theophyllins
DE2012644A1 (en) Beta-pyridylcarbinol esters with circulatory activity
DE1963318C (de) Silybinhalbestersauren des Silybins mit 1 und bzw oder 2 Mol Bernsteinsaure und deren Salze mit pharmakologisch ver traglichen anorganischen oder organischen Basen, und Arzneimittel

Legal Events

Date Code Title Description
PL Patent ceased